US2014155290A1PendingUtilityA1
Host cells comprising alpha 1, 2 mannosidase and culture methods thereof
Est. expiryDec 8, 2025(expired)· nominal 20-yr term from priority
Inventors:Christopher Kenyon Crowell
C12N 2510/02C12N 2501/999C12P 21/005C12N 15/85C07K 14/505C12N 9/2402C12N 5/0693C12Y 302/01024G01N 33/746C12N 2500/95C12Q 1/6809
65
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Improved host cells and culture methods involving overexpression of MAN1C1 activity to improve protein production are provided.
Claims
exact text as granted — not AI-modifiedWe claim:
1 . A host cell engineered to overexpress (a) alpha 1,2 mannosidase (MAN1C1) native to the host cell and (b) a glycoprotein of interest.
2 . The host cell of claim 1 wherein said host cell has been transfected with a vector comprising a nucleic acid encoding MAN1C1 operably linked to a heterologous expression control sequence.
3 . The host cell of claim 1 wherein said host cell comprises a heterologous expression control sequence operably linked to a nucleic acid encoding MAN1C1.
4 . The host cell of any of claims 1 - 3 wherein said host cell has been transfected with a vector comprising a nucleic acid encoding said glycoprotein of interest operably linked to a heterologous expression control sequence.
5 . The host cell of any of claims 1 - 3 wherein said host cell comprises a heterologous expression control sequence operably linked to a nucleic acid encoding said glycoprotein of interest.
6 . The host cell any of claims 1 - 5 wherein the glycoprotein of interest is an erythropoiesis-stimulating molecule.
7 . The host cell of claim 6 wherein the glycoprotein of interest is erythropoietin of SEQ ID NO: 3.
8 . The host cell of claim 6 wherein the glycoprotein of interest is darbepoetin of SEQ ID NO: 5.
9 . The host cell of any of claims 1 - 8 which is a mammalian cell.
10 . The host cell of any of claims 1 - 8 which is a CHO cell.
11 . The host cell of any of claims 1 - 8 which is a human cell.
12 . The host cell of any of claims 1 - 8 which is a BHK cell.
13 . The host cell of any of claims 1 - 8 which is an NS/0 cell.
14 . The host cell of any of claims 1 - 8 which is an HT-1080 cell.
15 . A method of producing a glycoprotein of interest comprising the steps of:
culturing the host cell of any of claims 1 - 14 in culture medium; and recovering the glycoprotein of interest from the host cell or culture medium.
16 . The method of claim 15 wherein said host is cultured under conditions that induce increased MAN1C1 expression.
17 . The method of claim 15 wherein said host cell expresses MAN1C1 protein at a level that increases specific productivity (pg/cell/day) of glycoprotein of interest produced.
18 . The method of claim 17 wherein at least a 2-fold increase in specific productivity is achieved by overexpression of MAN1C1.
19 . A method of increasing production of a glycoprotein of interest comprising the steps of:
culturing the host cell of any of claims 1 - 14 in culture medium under conditions that permit expression of MAN1C1 at levels that improve production of the glycoprotein of interest; and recovering the glycoprotein of interest from the host cell or culture medium.
20 . The method of claim 15 comprising the step of further adding an inducer of protein production to the culture medium.
21 . A method of screening for an inducer of protein production comprising the steps of:
(a) contacting a host cell with a candidate compound, (b) determining expression level of MAN1C1, and (c) identifying said candidate compound as an inducer of protein production if the expression level of MAN1C1 increases.
22 . The method of claim 21 wherein MAN1C1 mRNA expression level is determined.
23 . The method of claim 21 wherein MAN1C1 protein expression level is determined.Join the waitlist — get patent alerts
Track US2014155290A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.